Trevena Inc. [NASDAQ: TRVN] stock went on an upward path that rose over 49.16% on Monday, amounting to a one-week price increase of more than 19.87%. The company report on May 11, 2022 that Trevena Reports First Quarter 2022 Results and Provides Business Update.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
OLINVYK refocused commercial strategy initiated mid-Q1.
OLINVYK respiratory physiology study demonstrated statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects.
Over the last 12 months, TRVN stock dropped by -81.87%. The one-year Trevena Inc. stock forecast points to a potential upside of 90.54. The average equity rating for TRVN stock is currently 2.20, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $51.91 million, with 165.52 million shares outstanding and 162.39 million shares in the current float. Compared to the average trading volume of 1.15M shares, TRVN stock reached a trading volume of 7263808 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Trevena Inc. [TRVN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TRVN shares is $3.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TRVN stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Trevena Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on March 15, 2021. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on September 14, 2020, representing the official price target for Trevena Inc. stock. Previously, the target price had yet another raise to $5, while Cantor Fitzgerald analysts kept a Overweight rating on TRVN stock.
The Average True Range (ATR) for Trevena Inc. is set at 0.04, with the Price to Sales ratio for TRVN stock in the period of the last 12 months amounting to 86.52. The Price to Book ratio for the last quarter was 1.01, with the Price to Cash per share for the same quarter was set at 0.28.
TRVN Stock Performance Analysis:
Trevena Inc. [TRVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.87. With this latest performance, TRVN shares dropped by -24.36% in over the last four-week period, additionally sinking by -67.61% over the last 6 months – not to mention a drop of -81.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRVN stock in for the last two-week period is set at 48.16, with the RSI for the last a single of trading hit 54.12, and the three-weeks RSI is set at 45.23 for Trevena Inc. [TRVN]. The present Moving Average for the last 50 days of trading for this stock 0.3895, while it was recorded at 0.2398 for the last single week of trading, and 0.7668 for the last 200 days.
Insight into Trevena Inc. Fundamentals:
Trevena Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.80 and a Current Ratio set at 6.10.
Trevena Inc. [TRVN] Insider Position Details
There are presently around $7 million, or 22.10% of TRVN stock, in the hands of institutional investors. The top three institutional holders of TRVN stocks are: BLACKROCK INC. with ownership of 10,893,566, which is approximately -2.207% of the company’s market cap and around 3.00% of the total institutional ownership; VANGUARD GROUP INC, holding 7,076,218 shares of the stock with an approximate value of $1.44 million in TRVN stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.66 million in TRVN stock with ownership of nearly 8.118% of the company’s market capitalization.
25 institutional holders increased their position in Trevena Inc. [NASDAQ:TRVN] by around 1,999,427 shares. Additionally, 43 investors decreased positions by around 3,989,335 shares, while 26 investors held positions by with 27,301,978 shares. The mentioned changes placed institutional holdings at 33,290,740 shares, according to the latest SEC report filing. TRVN stock had 8 new institutional investments in for a total of 1,180,371 shares, while 9 institutional investors sold positions of 254,816 shares during the same period.